Literature DB >> 28234357

Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing.

Abhishek D Garg1,2, Lien Vandenberk3, Shentong Fang4, Tekele Fasche4, Sofie Van Eygen1, Jan Maes5, Matthias Van Woensel6,7, Carolien Koks3, Niels Vanthillo5, Norbert Graf8, Peter de Witte5, Stefaan Van Gool9, Petri Salven4, Patrizia Agostinis1.   

Abstract

Innate immune sensing of dying cells is modulated by several signals. Inflammatory chemokines-guided early recruitment, and pathogen-associated molecular patterns-triggered activation, of major anti-pathogenic innate immune cells like neutrophils distinguishes pathogen-infected stressed/dying cells from sterile dying cells. However, whether certain sterile dying cells stimulate innate immunity by partially mimicking pathogen response-like recruitment/activation of neutrophils remains poorly understood. We reveal that sterile immunogenic dying cancer cells trigger (a cell autonomous) pathogen response-like chemokine (PARC) signature, hallmarked by co-release of CXCL1, CCL2 and CXCL10 (similar to cells infected with bacteria or viruses). This PARC signature recruits preferentially neutrophils as first innate immune responders in vivo (in a cross-species, evolutionarily conserved manner; in mice and zebrafish). Furthermore, key danger signals emanating from these dying cells, that is, surface calreticulin, ATP and nucleic acids stimulate phagocytosis, purinergic receptors and toll-like receptors (TLR) i.e. TLR7/8/9-MyD88 signaling on neutrophil level, respectively. Engagement of purinergic receptors and TLR7/8/9-MyD88 signaling evokes neutrophil activation, which culminates into H2O2 and NO-driven respiratory burst-mediated killing of viable residual cancer cells. Thus sterile immunogenic dying cells perform 'altered-self mimicry' in certain contexts to exploit neutrophils for phagocytic targeting of dead/dying cancer cells and cytotoxic targeting of residual cancer cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28234357      PMCID: PMC5423108          DOI: 10.1038/cdd.2017.15

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  33 in total

Review 1.  Chemokines: multiple levels of leukocyte migration control.

Authors:  Bernhard Moser; Marlene Wolf; Alfred Walz; Pius Loetscher
Journal:  Trends Immunol       Date:  2004-02       Impact factor: 16.687

Review 2.  Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation.

Authors:  A D Garg; E Romano; N Rufo; P Agostinis
Journal:  Cell Death Differ       Date:  2016-02-19       Impact factor: 15.828

3.  Calreticulin exposure dictates the immunogenicity of cancer cell death.

Authors:  Michel Obeid; Antoine Tesniere; François Ghiringhelli; Gian Maria Fimia; Lionel Apetoh; Jean-Luc Perfettini; Maria Castedo; Grégoire Mignot; Theoharis Panaretakis; Noelia Casares; Didier Métivier; Nathanael Larochette; Peter van Endert; Fabiola Ciccosanti; Mauro Piacentini; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Med       Date:  2006-12-24       Impact factor: 53.440

Review 4.  Neutrophil migration in infection and wound repair: going forward in reverse.

Authors:  Sofia de Oliveira; Emily E Rosowski; Anna Huttenlocher
Journal:  Nat Rev Immunol       Date:  2016-05-27       Impact factor: 53.106

Review 5.  Apoptotic cell clearance: basic biology and therapeutic potential.

Authors:  Ivan K H Poon; Christopher D Lucas; Adriano G Rossi; Kodi S Ravichandran
Journal:  Nat Rev Immunol       Date:  2014-01-31       Impact factor: 53.106

6.  Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1.

Authors:  Shigeki Chiba; Muhammad Baghdadi; Hisaya Akiba; Hironori Yoshiyama; Ichiro Kinoshita; Hirotoshi Dosaka-Akita; Yoichiro Fujioka; Yusuke Ohba; Jacob V Gorman; John D Colgan; Mitsuomi Hirashima; Toshimitsu Uede; Akinori Takaoka; Hideo Yagita; Masahisa Jinushi
Journal:  Nat Immunol       Date:  2012-07-29       Impact factor: 25.606

7.  Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance.

Authors:  Michael R Elliott; Faraaz B Chekeni; Paul C Trampont; Eduardo R Lazarowski; Alexandra Kadl; Scott F Walk; Daeho Park; Robin I Woodson; Marina Ostankovich; Poonam Sharma; Jeffrey J Lysiak; T Kendall Harden; Norbert Leitinger; Kodi S Ravichandran
Journal:  Nature       Date:  2009-09-10       Impact factor: 49.962

8.  MET is required for the recruitment of anti-tumoural neutrophils.

Authors:  Veronica Finisguerra; Giusy Di Conza; Mario Di Matteo; Jens Serneels; Sandra Costa; A A Roger Thompson; Els Wauters; Sarah Walmsley; Hans Prenen; Zvi Granot; Andrea Casazza; Massimiliano Mazzone
Journal:  Nature       Date:  2015-05-18       Impact factor: 49.962

9.  Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids.

Authors:  C J Cambier; Kevin K Takaki; Ryan P Larson; Rafael E Hernandez; David M Tobin; Kevin B Urdahl; Christine L Cosma; Lalita Ramakrishnan
Journal:  Nature       Date:  2013-12-15       Impact factor: 49.962

10.  Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.

Authors:  Abhishek D Garg; Lorenzo Galluzzi; Lionel Apetoh; Thais Baert; Raymond B Birge; José Manuel Bravo-San Pedro; Karine Breckpot; David Brough; Ricardo Chaurio; Mara Cirone; An Coosemans; Pierre G Coulie; Dirk De Ruysscher; Luciana Dini; Peter de Witte; Aleksandra M Dudek-Peric; Alberto Faggioni; Jitka Fucikova; Udo S Gaipl; Jakub Golab; Marie-Lise Gougeon; Michael R Hamblin; Akseli Hemminki; Martin Herrmann; James W Hodge; Oliver Kepp; Guido Kroemer; Dmitri V Krysko; Walter G Land; Frank Madeo; Angelo A Manfredi; Stephen R Mattarollo; Christian Maueroder; Nicolò Merendino; Gabriele Multhoff; Thomas Pabst; Jean-Ehrland Ricci; Chiara Riganti; Erminia Romano; Nicole Rufo; Mark J Smyth; Jürgen Sonnemann; Radek Spisek; John Stagg; Erika Vacchelli; Peter Vandenabeele; Lien Vandenberk; Benoit J Van den Eynde; Stefaan Van Gool; Francesca Velotti; Laurence Zitvogel; Patrizia Agostinis
Journal:  Front Immunol       Date:  2015-11-20       Impact factor: 7.561

View more
  42 in total

1.  A Low-Molecular-Weight Compound Derived from Human Leukocytes Determines a Bactericidal Activity of the Interferon Preparation.

Authors:  A S Vasilchenko; V A Gritsenko; D B Kosyan; E A Rogozhin
Journal:  Probiotics Antimicrob Proteins       Date:  2019-09       Impact factor: 4.609

Review 2.  Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics.

Authors:  Abhishek D Garg; Sanket More; Nicole Rufo; Odeta Mece; Maria Livia Sassano; Patrizia Agostinis; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-10-04       Impact factor: 8.110

Review 3.  Trial watch: dendritic cell vaccination for cancer immunotherapy.

Authors:  Jenny Sprooten; Jolien Ceusters; An Coosemans; Patrizia Agostinis; Steven De Vleeschouwer; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi; Abhishek D Garg
Journal:  Oncoimmunology       Date:  2019-07-18       Impact factor: 8.110

Review 4.  Trial watch: Dendritic cell-based anticancer immunotherapy.

Authors:  Abhishek D Garg; Monica Vara Perez; Marco Schaaf; Patrizia Agostinis; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-05-12       Impact factor: 8.110

5.  Tumor cell-released autophagosomes (TRAP) enhance apoptosis and immunosuppressive functions of neutrophils.

Authors:  Rong Gao; Jie Ma; Zhifa Wen; Peiying Yang; Jinjin Zhao; Meng Xue; Yongqiang Chen; Mohanad Aldarouish; Hong-Ming Hu; Xue-Jun Zhu; Ning Pan; Li-Xin Wang
Journal:  Oncoimmunology       Date:  2018-03-06       Impact factor: 8.110

6.  Immunogenic necroptosis in the anti-tumor photodynamic action of BAM-SiPc, a silicon(IV) phthalocyanine-based photosensitizer.

Authors:  Ying Zhang; Ying-Kit Cheung; Dennis K P Ng; Wing-Ping Fong
Journal:  Cancer Immunol Immunother       Date:  2020-08-24       Impact factor: 6.968

7.  Effects of checkpoint kinase 1 inhibition by prexasertib on the tumor immune microenvironment of head and neck squamous cell carcinoma.

Authors:  Ritu Chaudhary; Robbert J C Slebos; Feifei Song; Keegan P McCleary-Sharpe; Jude Masannat; Aik Choon Tan; Xuefeng Wang; Nelusha Amaladas; Wenjuan Wu; Gerald E Hall; Jose R Conejo-Garcia; Juan C Hernandez-Prera; Christine H Chung
Journal:  Mol Carcinog       Date:  2020-12-30       Impact factor: 4.784

Review 8.  The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses.

Authors:  Tania Løve Aaes; Peter Vandenabeele
Journal:  Cell Death Differ       Date:  2020-11-19       Impact factor: 15.828

9.  Immunology of Cell Death in Cancer Immunotherapy.

Authors:  Lorenzo Galluzzi; Abhishek D Garg
Journal:  Cells       Date:  2021-05-15       Impact factor: 6.600

10.  Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.

Authors:  L Vanderbeke; P Van Mol; Y Van Herck; F De Smet; S Humblet-Baron; K Martinod; A Antoranz; I Arijs; B Boeckx; F M Bosisio; M Casaer; D Dauwe; W De Wever; C Dooms; E Dreesen; A Emmaneel; J Filtjens; M Gouwy; J Gunst; G Hermans; S Jansen; K Lagrou; A Liston; N Lorent; P Meersseman; T Mercier; J Neyts; J Odent; D Panovska; P A Penttila; E Pollet; P Proost; J Qian; K Quintelier; J Raes; S Rex; Y Saeys; J Sprooten; S Tejpar; D Testelmans; K Thevissen; T Van Buyten; J Vandenhaute; S Van Gassen; L C Velásquez Pereira; R Vos; B Weynand; A Wilmer; J Yserbyt; A D Garg; P Matthys; C Wouters; D Lambrechts; E Wauters; J Wauters
Journal:  Nat Commun       Date:  2021-07-05       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.